Indications for Use:

• Relief of neuromuscular blockade caused by rocuronium bromide or vecuronium bromide in adults.
• Relief of neuromuscular blockade caused by rocuronium bromide in children and adolescents aged 2 to 17 years.

This product is included in the Essential Drug List (EDL).

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical instruction for Sudjecta^®, solution for intravenous administration, 100 mg/ml, please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx